Parker Hannifin
PH
$949.47
-0.67%
Parker-Hannifin Corporation is a global leader in motion and control technologies, providing precision-engineered solutions for aerospace, industrial, and mobile markets, including hydraulic, pneumatic, and electromechanical systems. The company differentiates itself through its vast portfolio of critical components and systems, which are designed to work together, fostering high cross-selling and deep customer relationships. Currently, the stock is in focus due to its strategic acquisition of CIRCOR's aerospace business, which is expected to enhance growth and margins, alongside a robust performance in its diversified industrial segment despite broader market volatility. Investors are also debating the sustainability of its growth trajectory amid cyclical industrial demand and the integration of recent acquisitions.…
PH
Parker Hannifin
$949.47
Related headlines
Investment Opinion: Should I buy PH Today?
Based on the analysis, PH is rated a Buy, supported by strong fundamentals, a strategic acquisition, and analyst consensus. The average analyst target of $1,160.95 implies a ~20.6% upside, and the recommendation mean of 1.68 indicates a Buy stance. The thesis is that Parker-Hannifin's growth acceleration, margin expansion, and acquisition synergies will drive earnings growth that justifies the premium valuation.
Sign up to view all
PH 12-Month Price Forecast
The AI assessment is bullish, driven by strong fundamental performance and positive catalysts. The company's revenue growth is accelerating, profitability is superior, and the acquisition of CIRCOR's aerospace business is expected to enhance growth and margins. However, the high valuation and cyclical risks temper confidence. The stance would be upgraded if the stock pulls back to a more reasonable valuation or if revenue growth accelerates further, while a downgrade would occur if integration issues or a downturn materialize.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Parker Hannifin's 12-month outlook, with a consensus price target around $1160.95 and implied upside of +22.3% versus the current price.
Average Target
$1160.95
0 analysts
Implied Upside
+22.3%
vs. current price
Analyst Count
—
covering this stock
Price Range
$680 - $1358
Analyst target range
The target price range spans from a low of $680.00 to a high of $1,358.00, showing a wide dispersion that reflects uncertainty about the pace of aerospace recovery and industrial cyclicality. The high target assumes successful integration of the CIRCOR acquisition, continued margin expansion, and robust growth in both segments, potentially leading to multiple expansion. The low target likely prices in a severe industrial downturn or integration challenges, which could compress earnings and the multiple. The wide spread (approximately 99% between low and high) indicates elevated uncertainty, but the recent pattern of reaffirmations and no downgrades suggests analysts are becoming more confident in the company's ability to execute its growth strategy.
Bulls vs Bears: PH Investment Factors
Parker-Hannifin presents a compelling growth story with strong revenue acceleration, superior profitability, and a strategic acquisition that could drive further upside. However, the stock trades at a significant premium to its historical average and industry peers, leaving limited margin of safety. The bull case is supported by robust fundamentals and analyst optimism, while the bear case hinges on valuation risk and cyclical vulnerability. The most critical tension is whether the company can sustain its high growth and margin expansion to justify the premium multiple, or if a cyclical downturn or integration misstep will trigger a de-rating. Currently, the evidence slightly favors the bulls given the consistent execution and positive catalysts, but investors should be mindful of the elevated expectations.
Bullish
- Strong Revenue Growth: Q3 FY2026 revenue grew 10.6% YoY to $5.486B, with sequential acceleration from $5.084B in Q1 to $5.486B in Q3, indicating robust demand across aerospace and industrial segments.
- High Profitability and ROE: Net margin of 16.98% and ROE of 23.69% significantly exceed industry averages (12.3% and ~15%), demonstrating operational efficiency and strong capital allocation.
- Strategic Acquisition Upside: The CIRCOR aerospace acquisition is expected to immediately boost growth, margins, and EPS, with analysts projecting EPS growth of ~37.7% (trailing PE 33.86x vs forward 24.58x).
- Analyst Consensus Buy: With a mean recommendation of 1.68 (Buy) and an average target of $1,160.95, the stock offers ~20.6% upside from the current price of $962.59, reflecting confidence in execution.
Bearish
- Rich Valuation: Trailing PE of 33.86x is near the top of its 3-year range (17.66x-33.86x) and at a 50.5% premium to the industry average of 22.5x, leaving little room for error.
- High PEG Ratio: PEG ratio of 6.80 suggests the stock is overvalued relative to its expected earnings growth, implying that growth expectations may already be priced in.
- Cyclicality and Market Sensitivity: With a beta of 1.128, PH is more volatile than the market, and its industrial end-markets are cyclical; a downturn could significantly impact revenue and margins.
- Integration Risks: The CIRCOR acquisition carries integration risks, including potential cost overruns, cultural clashes, or failure to achieve synergies, which could erode the expected benefits.
PH Technical Analysis
Parker-Hannifin's stock is in a strong long-term uptrend, with a 1-year price change of +27.17%, significantly outperforming the S&P 500's +18.65% over the same period. The current price of $962.59 sits at 87.5% of its 52-week range (low $715.37, high $1099.94), indicating the stock is trading near its highs, which reflects robust momentum but also potential overextension. The stock's beta of 1.128 suggests slightly higher volatility than the market, which is important for risk management.
Beta
1.12
1.12x market volatility
Max Drawdown
-19.5%
Largest decline past year
52-Week Range
$715-$1100
Price range past year
Annual Return
+25.7%
Cumulative gain past year
| Period | PH Return | S&P 500 |
|---|---|---|
| 1m | -10.5% | -1.4% |
| 3m | +5.2% | +3.3% |
| 6m | +6.7% | +15.1% |
| 1y | +25.7% | +17.2% |
| ytd | +6.2% | +11.8% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
PH Fundamental Analysis
Parker-Hannifin's revenue has been growing steadily, with the most recent quarter (Q3 FY2026, ending March 31, 2026) reporting $5.486 billion, up 10.6% year-over-year. This growth is driven by both the Aerospace Systems segment ($1.706 billion) and the Diversified Industrial segment ($3.468 billion), with the latter benefiting from strong demand in automation and mobile markets. The multi-quarter trend shows consistent expansion, with revenue rising from $5.084 billion in Q1 FY2026 to $5.486 billion in Q3, indicating accelerating growth. This robust top-line performance supports the investment case, though investors should monitor cyclical risks in industrial end-markets.
Quarterly Revenue
$5.5B
2026-03
Revenue YoY Growth
+10.6%
YoY Comparison
Gross Margin
36.8%
Latest Quarter
Free Cash Flow
$3.7B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is PH Overvalued?
Given Parker-Hannifin's positive net income, the trailing P/E ratio of 33.86x is the primary valuation metric, while the forward P/E of 24.58x indicates the market expects significant earnings growth. The gap between trailing and forward multiples implies a projected EPS increase of about 37.7%, reflecting optimism about margin expansion and acquisition synergies. Compared to the industry average P/E of 22.5x (from valuation data), Parker-Hannifin trades at a 50.5% premium, which is justified by its superior profitability (net margin of 16.98% vs. industry average of 12.3%) and strong ROE of 23.69%. Historically, the stock's P/E has ranged from 17.66x to 33.86x over the past three years, and the current level is near the top of that band, suggesting the market is pricing in optimistic expectations for continued growth and operational excellence.
PE
33.9x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 18x~33x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
26.5x
Enterprise Value Multiple
Investment Risk Disclosure
Financial and operational risks include the company's debt-to-equity ratio of 0.55, which is moderate but could increase with the CIRCOR acquisition, potentially raising interest expenses and financial leverage. The net margin of 16.98% is high, but any margin compression from raw material costs or integration issues could impact profitability. Revenue concentration in cyclical industrial markets (Diversified Industrial segment generated $3.468B in Q3, ~63% of total revenue) exposes the company to economic downturns, as seen in the -19.52% max drawdown over the past year. Additionally, the company's free cash flow of $3.68B TTM is positive, but the payout ratio of 25.65% indicates a moderate dividend, which could be at risk if cash flows decline.
FAQ
The key risks are: 1) Valuation risk - the stock trades at a premium PE of 33.86x, leaving little room for error; a de-rating could cause significant losses. 2) Cyclical risk - the industrial segment is sensitive to economic cycles; a downturn could reduce revenue and margins. 3) Integration risk - the CIRCOR acquisition may face execution challenges, failing to deliver expected synergies. 4) Market risk - with a beta of 1.128, the stock is more volatile than the market, so a broad selloff could amplify losses. The most severe risk is a combination of these factors, potentially leading to a -25% decline to the 52-week low.
The 12-month forecast is moderately bullish. In the base case (50% probability), the stock is expected to trade in the range of $1,050-$1,200, with an average target of $1,160.95. In the bull case (30% probability), it could reach $1,100-$1,358, driven by successful integration and strong growth. In the bear case (20% probability), it could fall to $680-$800, if a downturn or integration issues occur. The most likely scenario is the base case, assuming continued execution and stable macro conditions. Investors should monitor quarterly earnings for signs of growth deceleration or margin pressure.
PH is currently overvalued relative to its historical average and industry peers. The trailing PE of 33.86x is near the top of its 3-year range (17.66x-33.86x) and 50.5% above the industry average of 22.5x. The forward PE of 24.58x is more reasonable, implying expected EPS growth of ~37.7%. The market is pricing in strong growth and margin expansion, which may be justified given the company's track record. However, the PEG ratio of 6.80 suggests that the stock is expensive relative to its growth rate. Investors are paying a premium for quality, and any disappointment could lead to multiple compression.
PH is a good buy for investors with a long-term horizon and a tolerance for moderate risk. The stock offers a ~20.6% upside to the average analyst target of $1,160.95, supported by strong revenue growth of 10.6% YoY and superior profitability (net margin 16.98%). However, the stock trades at a premium valuation (PE 33.86x trailing), so it is not a value pick. The main downside risk is a cyclical downturn or integration issues with the CIRCOR acquisition, which could lead to a -25% decline to the 52-week low. For growth-oriented investors, it is a solid buy, but value investors may want to wait for a pullback.
PH is more suitable for long-term investment due to its growth trajectory and cyclical nature. The company has a beta of 1.128, indicating higher volatility, which makes short-term trading risky. Over the past year, the stock has gained 27.17%, but it has also experienced drawdowns of up to -19.52%. For long-term investors, the company's strong fundamentals, including revenue growth of 10.6% YoY and ROE of 23.69%, suggest it can compound value over time. The dividend yield of 0.76% provides a modest income. A minimum holding period of 3-5 years is recommended to ride out cyclical fluctuations and benefit from the acquisition synergies.